Cystic fibrosis year in review 2019: Section 1 CFTR modulators

Adrienne P. Savant*, Susanna A. McColley

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


During the year 2019, research and case reports/series in the field of cystic fibrosis (CF) were in abundance. To adequately address the large body of CF research published during 2019, the CF year in review will be divided into three sections. This report is the first section, focusing specifically on new research related to cystic fibrosis transmembrane conductance regulator modulator therapy. Additional sections will concentrate on pulmonary and infections research and the multisystem effects of CF. It is an exciting time to be providing care for patients and their families with CF with all the exciting new discoveries that will be shared in these reviews.

Original languageEnglish (US)
Pages (from-to)3236-3242
Number of pages7
JournalPediatric Pulmonology
Issue number12
StatePublished - Dec 2020


  • clinical trials
  • cystic fibrosis
  • evidence-based medicine and outcomes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Cystic fibrosis year in review 2019: Section 1 CFTR modulators'. Together they form a unique fingerprint.

Cite this